The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.
Related resource: Generic Drug Registration Application (ANDA) in China
| No. | Drug Name | Dosage Form | Brand Name | Strength | MAH | Note 1 | Note 2 | Batch |
| 79-1 | view | view | / | view | FRESENIUS KABI USA LLC | Original drug not imported to China | US Orange Book | The 79th Batch of Reference Listed Drugs |
| 79-2 | view | view | CAMZYOS | view | Bristol-Myers Squibb Co | Original drug not imported to China | US Orange Book | The 79th Batch of Reference Listed Drugs |
| 79-3 | view | view | CAMZYOS | view | Bristol-Myers Squibb Co | Original drug not imported to China | US Orange Book | The 79th Batch of Reference Listed Drugs |
| 79-4 | view | view | CAMZYOS | view | Bristol-Myers Squibb Co | Original drug not imported to China | US Orange Book | The 79th Batch of Reference Listed Drugs |
| 79-5 | view | view | CAMZYOS | view | Bristol-Myers Squibb Co | Original drug not imported to China | US Orange Book | The 79th Batch of Reference Listed Drugs |
| 79-6 | view | view | フィジオ | view | Otsuka Pharmaceutical Factory, Inc. (株式会社大塚製薬工場) | Original drug not imported to China | Approved in Japan | The 79th Batch of Reference Listed Drugs |
| 79-7 | view | view | Salonpas | view | Hisamitsu Pharmaceutical Co Inc | Original drug not imported to China | US Orange Book | The 79th Batch of Reference Listed Drugs |
| 79-8 | view | view | Salonpas | view | Hisamitsu Pharmaceutical Co Inc | Original drug not imported to China | US Orange Book | The 79th Batch of Reference Listed Drugs |
| 79-9 | view | view | Igalmi | view | BioXcel Therapeutics Inc | Original drug not imported to China | US Orange Book | The 79th Batch of Reference Listed Drugs |
| 79-10 | view | view | Igalmi | view | BioXcel Therapeutics Inc | Original drug not imported to China | US Orange Book | The 79th Batch of Reference Listed Drugs |
